PTEN INACTIVATION AND ALTERATION OF THE PI3K/AKT/mTOR PATHWAY IN BILIARY TRACT CANCER

被引：0
|
作者：
Petzold, J. [1 ]
Lederer, E. [1 ]
Reihs, R. [1 ]
Ernst, C. [1 ]
Bettermann, K. [1 ]
Halbwedl, I. [1 ]
Lax, S. [2 ]
Park, Y. N. [3 ]
Kim, K. S. [4 ]
Kiesslich, T. [5 ]
Pichler, M. [6 ]
Obrist, P. [7 ]
Haybaeck, J. [1 ]
机构：
[1] Med Univ Graz, Inst Pathol, Graz, Austria
[2] Hosp Graz West, Dept Pathol, Graz, Austria
[3] Yonsei Univ, Coll Med, Dept Pathol, Project Med Sci BK21PLUS, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea
[5] Paracelsus Med Univ, Inst Physiol & Pathophysiol, Salzburg, Austria
[6] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
[7] Inst Pathol, Zams, Austria
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
244
引用
收藏
页码：5942 / 5943
页数：2
相关论文
共 50 条
  • [21] Targeting the PI3K/Akt/mTOR pathway for cancer prevention.
    Dennis, PA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2800S - 2801S
  • [22] The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
    Mabuchi, Seiji
    Kuroda, Hiromasa
    Takahashi, Ryoko
    Sasano, Tomoyuki
    GYNECOLOGIC ONCOLOGY, 2015, 137 (01) : 173 - 179
  • [23] Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy
    Justin Cidado
    Ben Ho Park
    Journal of Mammary Gland Biology and Neoplasia, 2012, 17 : 205 - 216
  • [24] Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
    Polivka, Jiri, Jr.
    Janku, Filip
    PHARMACOLOGY & THERAPEUTICS, 2014, 142 (02) : 164 - 175
  • [25] The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
    Dobbin, Zachary C.
    Landen, Charles N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (04): : 8213 - 8227
  • [26] PI3K/Akt/mTOR signaling pathway in cancer stem cells
    Fath, Mohsen Karami
    Ebrahimi, Menooa
    Nourbakhsh, Ehsan
    Hazara, Ahmad Zia
    Mirzaei, Ali
    Shafieyari, Saba
    Salehi, Azadeh
    Hoseinzadeh, Mahsa
    Payandeh, Zahra
    Barati, Ghasem
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 237
  • [27] RAS Signaling in the PI3K/AKT/MTOR Pathway
    Nussinov, Ruth
    Zhang, Mingzhen
    Jang, Hyunbum
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 51A - 51A
  • [28] Clinical Significance of Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway in Korean Patients with Colorectal Cancer
    Kim, Jong Gwang
    Chae, Yee Soo
    Sohn, Sang Kyun
    Kang, Byung Woog
    Moon, Joon Ho
    Lee, Soo Jung
    Jeon, Seong Woo
    Park, Jun Seok
    Park, Jin Young
    Choi, Gyu Seog
    ONCOLOGY, 2010, 79 (3-4) : 278 - 282
  • [29] THE PI3K/AKT MTOR PATHWAY IN OLIGODENDROCYTE DIFFERENTIATION
    Wood, T.
    Tyler, W.
    Gangoli, N.
    Gokina, P.
    Kim, H.
    Covey, M.
    Levison, S.
    GLIA, 2009, 57 (13) : S20 - S20
  • [30] Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors
    Xu, G
    Zhang, WH
    Bertram, P
    Zheng, XF
    McLeod, H
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 24 (04) : 893 - 900
12345